The Importance of Lesion-specific FFRCT Values in the Non-invasive Assessment of CAD: A Case-based Discussion

Sponsored by HeartFlow

Join us!

Lesion-specific physiology matters! Three leading experts review cases that demonstrate why and how lesion-specific physiology can inform treatment for patients with CAD and lessons learned from 10 years of FFRCT interpretation.

Learning Objectives: 

  • Discuss how lesion-specific physiologic assessment provides more actionable information to treat patients
  • Explore translesional pressure loss with FFRCT 
  • Understand why a binary-only physiology value may be insufficient in CAD diagnosis and treatment
  • Review how lesion-specific physiology informs treatment in the cath lab

Who should attend: 

  • Cardiologists
  • Interventional Cardiologists
  • General Practitioners
  • NPs
  • PAs
  • CV Nurses
  • Cardiovascular Imaging Specialists
  • Cardiovascular Service Line Directors
  • Cath Lab Directors
  • CT Technologists

Expert Presenters: 

Leipsic

Jonathon Leipsic, MD, FRCPC, MSCCT
Past President, SCCT
Vancouver, BC, Canada

Rabbat

Mark Rabbat, MD, FSCCT, FACC, FAHA
Director, Cardiac CT and Structural Heart Interventional Imaging
Loyola University Medical Center, Chicago, IL

Barker

Colin Barker, MD, MD, FACC, FSCAI
Director, Interventional and Structural Cardiology
Vanderbilt University Medical Center, Nashville, TN